Literature DB >> 2042988

Polymyositis, not polymyalgia rheumatica.

N D Hopkinson1, D J Shawe, J M Gumpel.   

Abstract

The distinction between polymyalgia rheumatica and polymyositis is important for treatment and prognosis. Four elderly patients were diagnosed and treated for polymyalgia: raised creatine kinase led to muscle biopsy and a diagnosis of polymyositis.

Entities:  

Mesh：

Year:  1991        PMID： 2042988      PMCID： PMC1004419          DOI： 10.1136/ard.50.5.321

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  9 in total

1.  Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.

Authors:  V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

2.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

3.  The epidemiology of polymyositis.

Authors:  T A Medsger; W N Dawson; A T Masi
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

Review 4.  Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature.

Authors:  M C Hochberg; D Feldman; M B Stevens
Journal:  Semin Arthritis Rheum       Date:  1986-02       Impact factor: 5.532

5.  Polymyositis: its presentation, morbidity and mortality.

Authors:  R DeVere; W G Bradley
Journal:  Brain       Date:  1975-12       Impact factor: 13.501

6.  The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.

Authors:  B A Bengtsson; B E Malmvall
Journal:  Arthritis Rheum       Date:  1981-07

7.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

8.  Polymyalgia rheumatica and corticosteroids: how much for how long?

Authors:  A R Behn; T Perera; A B Myles
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

9.  An evaluation of criteria for polymyalgia rheumatica.

Authors:  H A Bird; W Esselinckx; A S Dixon; A G Mowat; P H Wood
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103
  9 in total
  2 in total

Review 1.  [Diagnostics and treatment of polymyalgia rheumatica].

Authors:  C Dejaco; E L Matteson; F Buttgereit
Journal:  Z Rheumatol       Date:  2016-09       Impact factor: 1.372

2.  Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series.

Authors:  Gianluca Sambataro; Domenico Sambataro; Francesca Pignataro; Sebastiano Emanuele Torrisi; Ada Vancheri; Mauro Pavone; Stefano Palmucci; Nicoletta Del Papa; Carlo Vancheri
Journal:  Respir Med Case Rep       Date:  2018-12-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.